CLINICAL_TRIALS
trial_result
· 2022-05-27
Clinical Trial Update: Evaluation of EpiBone-CMF for Mandibular Ramus Reconstruction [Phase 1, Phase 2]
Summary
Phase 1/2 clinical trial evaluating EpiBone-CMF for mandibular reconstruction is ongoing with unclear status.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Epibone, Inc. | Conditions: Mandible Tumor, Mandibular Injuries | Phase 1, Phase 2 | Status: UNKNOWN